Form 4 for CRMD CorMedix Inc.
Accepted 2026-01-14 00:00:00 ET · period of report 2026-01-12 · accession 0001213900-26-004470 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-14 | 2026-01-12 | CRMD | Lefkowitz Steven W | Dir | M - OptEx | $5.63 | +15.0K | 95.5K | +19% | +$84.5K |
| D | 2026-01-14 | 2026-01-12 | CRMD | Lefkowitz Steven W | Dir | M - OptEx | $0.00 | -15.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-12 | M | A | 15,000 | $5.63 | 95,498 | D | — | — | (F1) The Reporting Person acquired stock through the exercise of options granted on 02/25/2020. The Reporting Person paid the exercise price in cash. No sales of stock were made. |
| 2 | Derivative | Stock Option (Right to Buy Common Stock) | 2026-01-12 | M | D | 15,000 | $0.00 | 0 | D | $5.63 · — to 2030-02-25 | 15,000 Common Stock | (F3) These stock options, representing a right to purchase 15,000 shares of Common Stock, were granted on 02/25/2020. These stock options are fully vested. |